| 10323092 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang |
2019-06-18 |
| 10323093 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang |
2019-06-18 |
| 10316090 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang |
2019-06-11 |
| 10316091 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang |
2019-06-11 |
| 10308714 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang |
2019-06-04 |
| 10266594 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang |
2019-04-23 |
| 10266595 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang |
2019-04-23 |
| 10266596 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang |
2019-04-23 |